INTRAOPERATIVE REAL TIME IMAGING WITH A DUAL RADIOACTIVE/FLUORESCENCE MODALITY FOR SENTINEL NODE LOCALIZATION. A FEASIBILITY STUDY INCLUDING REPRODUCIBILITY OF MULTIMODALITY LYMPHATIC MAPPING WITH A COCKTAIL TRACER CONTAINING 99mTc NANOCOLLOID /ICG

INTRAOPERATIVE REAL TIME IMAGING WITH A DUAL RADIOACTIVE/FLUORESCENCE MODALITY FOR SENTINEL NODE LOCALIZATION. A FEASIBILITY STUDY INCLUDING REPRODUCIBILITY OF MULTIMODALITY LYMPHATIC MAPPING WITH A COCKTAIL TRACER CONTAINING 99mTc NANOCOLLOID /ICG - RADIOACTIVE/FLUORESCENCE MODALITY FOR SENTINEL NODE LOCALIZATION.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33218

Enrollment

Registered

2009-05-25

Start date

2012-01-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients presenting cutaneous melanoma of head/neck and upper part of the trunk Patients presenting oral cavity malignances T1-2N0 Breast cancer patients with a medially located tumor (palpable tumors and non-palpable tumors detectable by ultrasound) with demonstrated drainage outside the axilla Patients with clinical N0 stage

Exclusion criteria

Exclusion criteria: Evidence of regional or distant metastases Non-palpable breast tumors requiring stereotaxis for tracer administration Incapacity or unwillingness of participant to give written informed consent Allergy to iodides

Design outcomes

Primary

Measure	Time frame
1.number and location of sentinel nodes after 99mTc-nanocolloid injection 2.number and location of sentinel nodes after cocktail injection 3.different locations and number of sentinel nodes after first injection 4.surgical retrieval rate and procedure time	—

Secondary

Measure	Time frame
None	—

Countries

Netherlands

Outcome results